References
1. Weaver SC, Barrett AD (2004) Transmission
cycles, host range, evolution and emergence of
arboviral disease. Nat Rev Microbiol 2
(10):789–801
2. King AM, Adams MJ, Lefkowitz EJ, Carstens
EB (2012) Virus taxonomy. In: IXth report of
the International Committee on Taxonomy of
Viruses, vol 9. Academic Press, San Diego, CA
3. Dick G, Kitchen S, Haddow A (1952) Zika
virus (I). Isolations and serological specificity.
Trans R Soc Trop Med Hyg 46(5):509–520
4. Wikan N, Smith DR (2016) Zika virus: history
of a newly emerging arbovirus. Lancet Infect
Dis 16(7):E119–E126
5. Cao-Lormeau VM, Roche C, Teissier A,
Robin E, Berry AL, Mallet HP, Sall AA,
Musso D (2014) Zika virus, French Polynesia,
South Pacific, 2013. Emerg Infect Dis 20
(6):1085–1086
6. Esposito DLA, de Moraes JB, Antonio Lopes
da Fonseca B (2018) Current priorities in the
Zika response. Immunology 153(4):435–442
7. Musso D, Gubler DJ (2016) Zika virus. Clin
Microbiol Rev 29(3):487–524
8. Krauer F, Riesen M, Reveiz L, Oladapo OT,
Martinez-Vega R, Porgo TV, Haefliger A,
Broutet NJ, Low N, Group WHOZCW
(2017) Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre
syndrome: systematic review. PLoS Med 14(1):
e1002203
9. Barrett AD, Teuwen DE (2009) Yellow fever
vaccine - how does it work and why do rare
cases of serious adverse events take place? Curr
Opin Immunol 21(3):308–313
10. Yun SI, Lee YM (2014) Japanese encephalitis:
the virus and vaccines. Hum Vaccin Immunother 10(2):263–279
11. Halstead SB (2017) Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35(47):6355–6358
12. Krol E, Brzuska G, Szewczyk B (2019) Production and biomedical application of flaviviruslike particles. Trends Biotechnol 37:1202
13. Wikan N, Suputtamongkol Y, Yoksan S, Smith
DR, Auewarakul P (2016) Immunological evidence of Zika virus transmission in Thailand.
Asian Pac J Trop Med 9(2):136–139
14. Henchal EA, Gentry MK, McCown JM,
Brandt WE (1982) Dengue virus-specific and
flavivirus group determinants identified with
monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 31
(4):830–836
Zika Virus-Like Particles
203
1. Weaver SC, Barrett AD (2004) Transmission
cycles, host range, evolution and emergence of
arboviral disease. Nat Rev Microbiol 2
(10):789–801
2. King AM, Adams MJ, Lefkowitz EJ, Carstens
EB (2012) Virus taxonomy. In: IXth report of
the International Committee on Taxonomy of
Viruses, vol 9. Academic Press, San Diego, CA
3. Dick G, Kitchen S, Haddow A (1952) Zika
virus (I). Isolations and serological specificity.
Trans R Soc Trop Med Hyg 46(5):509–520
4. Wikan N, Smith DR (2016) Zika virus: history
of a newly emerging arbovirus. Lancet Infect
Dis 16(7):E119–E126
5. Cao-Lormeau VM, Roche C, Teissier A,
Robin E, Berry AL, Mallet HP, Sall AA,
Musso D (2014) Zika virus, French Polynesia,
South Pacific, 2013. Emerg Infect Dis 20
(6):1085–1086
6. Esposito DLA, de Moraes JB, Antonio Lopes
da Fonseca B (2018) Current priorities in the
Zika response. Immunology 153(4):435–442
7. Musso D, Gubler DJ (2016) Zika virus. Clin
Microbiol Rev 29(3):487–524
8. Krauer F, Riesen M, Reveiz L, Oladapo OT,
Martinez-Vega R, Porgo TV, Haefliger A,
Broutet NJ, Low N, Group WHOZCW
(2017) Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre
syndrome: systematic review. PLoS Med 14(1):
e1002203
9. Barrett AD, Teuwen DE (2009) Yellow fever
vaccine - how does it work and why do rare
cases of serious adverse events take place? Curr
Opin Immunol 21(3):308–313
10. Yun SI, Lee YM (2014) Japanese encephalitis:
the virus and vaccines. Hum Vaccin Immunother 10(2):263–279
11. Halstead SB (2017) Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35(47):6355–6358
12. Krol E, Brzuska G, Szewczyk B (2019) Production and biomedical application of flaviviruslike particles. Trends Biotechnol 37:1202
13. Wikan N, Suputtamongkol Y, Yoksan S, Smith
DR, Auewarakul P (2016) Immunological evidence of Zika virus transmission in Thailand.
Asian Pac J Trop Med 9(2):136–139
14. Henchal EA, Gentry MK, McCown JM,
Brandt WE (1982) Dengue virus-specific and
flavivirus group determinants identified with
monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 31
(4):830–836
Zika Virus-Like Particles
203